Education
About Us
Working with TipRanks
Follow Us
Tilray (TLRY)
NASDAQ:TLRY
Earnings Data
Report Date
Apr 14, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-0.15Last Year’s EPS
-8.7Same Quarter Last Year
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented multiple meaningful operational and financial improvements: record quarterly revenue, stronger international cannabis and distribution growth, improved margins in cannabis and distribution, a markedly stronger cash position and a significant reduction in operating cash burn and net loss year-over-year. Key execution risks remain, notably beverage segment underperformance, ongoing GAAP net losses, regulatory uncertainty (particularly U.S. hemp-derived THC) and permit/price pressure in parts of Europe. On balance, management emphasized concrete progress, cost savings, reaffirmed guidance and strategic readiness for regulatory shifts, while acknowledging areas still requiring work.Company Guidance
Record Quarterly Revenue
Reported record Q2 net revenue of $217.5M (CEO rounded to $218M), beating analyst expectations despite headwinds.
Profitability and Cash Operating Results
Adjusted EBITDA of $8.4M and positive adjusted cash operating income of $6M for the quarter; adjusted EPS loss of $0.02 reported.
Strong International Cannabis Growth
Global cannabis net revenue of $67.5M with international cannabis up 36% year-over-year and sequential growth of 51% to ~$20M, driven by higher-margin international markets.
Distribution (Tilray Pharma) Momentum
Distribution revenue of $85.3M, the largest quarter ever for the segment, increasing 26% year-over-year and 15% sequentially while improving gross margins.
Balance Sheet and Liquidity Strengthened
Ended the quarter with $291.6M in cash and marketable securities, reduced debt by ~$4M in Q2 and moved from a net debt position to a net cash position of nearly $30M.
Material Improvement in Cash Flow and Net Loss
Cash flow used in operations improved to $8.5M from $40.7M (a $32.2M improvement); net loss narrowed to $43.5M, a 49% improvement year-over-year (from $85.3M).
Canadian Operational Highlights and Capacity Expansion
Highest quarterly Canadian shipment volume in two years with >5.5M units shipped; completed Cayuga outdoor harvest that increased cultivation capacity to ~200 metric tons annually (company referenced broader Canadian capability up to ~270 metric tons).
Progress on Cost Savings and Guidance Reaffirmed
Delivered $27M of annualized cost savings in H1 under Project 420, on track to $33M target; reaffirmed FY26 adjusted EBITDA guidance of $62M–$72M.
Tilray Medical Scale and R&D Leadership
Tilray Medical run-rate expected ~ $150M annually; offers 200+ medical cannabis products, serves >500k registered patients and participated in 25+ clinical studies—positioned as science-driven global medical operator.
Margin Improvements in Key Segments
Overall gross profit $57.5M and gross margin 26%; cannabis gross margin improved to 39% from 35% a year ago (+4 percentage points); distribution gross margin rose to 13% from 12%; wellness margin improved to 32% from 31%.
TLRY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TLRY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jan 08, 2026 | $9.13 | ― | ― |
Oct 09, 2025 | $17.20 | $21.00 | +22.09% |
Jul 28, 2025 | $7.00 | $5.77 | -17.57% |
Apr 08, 2025 | $5.79 | $4.56 | -21.24% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Tilray (TLRY) report earnings?
Tilray (TLRY) is schdueled to report earning on Apr 14, 2026, After Close (Confirmed).
What is Tilray (TLRY) earnings time?
Tilray (TLRY) earnings time is at Apr 14, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TLRY EPS forecast?
TLRY EPS forecast for the fiscal quarter 2026 (Q3) is -0.15.
